Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Alvogen, Inc to request your refund or repair — edit it as you like.
Subject: Recall D-0649-2021 — Alvogen, Inc Alvogen, Inc recalls Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches Hello, I own a Alvogen, Inc recalls Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: that is covered by recall D-0649-2021 from Alvogen, Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
